Skip to main content
. 2023 Oct 4;2023(10):CD004417. doi: 10.1002/14651858.CD004417.pub6

Pichichero 1987.

Study characteristics
Methods Open randomised controlled trial over 27 months
Participants 114 children with sore throat (suspected GABHS) were included who presented to 1 private paediatric practice in New York State, USA. Of these 114 children, 55 were randomised to delayed antibiotics and 59 were randomised to immediate antibiotics.
Age: of the 55 children randomised to delayed antibiotics, the average age was 7.8 years (SD 2.3); of the 59 children randomised to immediate antibiotics, it was 7.5 years (SD 2.6)
Sex: not reported
Exclusion criteria included hypersensitivity to penicillin, receipt of antibiotics in preceding 7 days, acute illness in preceding 7 days, GABHS infection in the preceding month and concurrent treatment with an antibiotic other than penicillin
Interventions Children were randomised to delayed antibiotics (48‐hour delay) versus immediate antibiotics. Children in each group received penicillin V 250 mg 3 times a day for 10 days.
Outcomes Primary outcomes: fever, duration of fever, malaise
Secondary outcomes: reconsultation rates, vomiting
Outcomes were measured using a symptom diary and reassessment at the paediatrician's office 3 days after child's initial enrolment
Notes This study was funded by the Robert Wood Johnson Foundation, Eli Lilly and Company, and Elmwood Paediatric Research fund. We approached the authors for their study data, but they did not provide this information.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Table of random numbers
Allocation concealment (selection bias) High risk Allocation concealment measures were not described
Blinding (performance bias and detection bias)
All outcomes Low risk Participant and doctor blinded, but there was no description of outcome assessor blinding
Incomplete outcome data (attrition bias)
All outcomes Low risk No participants dropped out
Selective reporting (reporting bias) Low risk Prespecified outcomes were reported
Other bias High risk Funded by philanthropic organisation and Eli Lilly